Medivolve Valuation
| MEDVF Stock | USD 0 0.00 0.00% |
Medivolve seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Medivolve from analyzing the firm fundamentals such as Current Valuation of (972.47 K), return on equity of -1.25, and Profit Margin of (0.11) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Medivolve's price fluctuation is very steady at this time. Calculation of the real value of Medivolve is based on 3 months time horizon. Increasing Medivolve's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Medivolve pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Medivolve. Since Medivolve is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medivolve Pink Sheet. However, Medivolve's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.002 | Real 0.00168 | Hype 0.002 | Naive 0.002 |
The real value of Medivolve Pink Sheet, also known as its intrinsic value, is the underlying worth of Medivolve Company, which is reflected in its stock price. It is based on Medivolve's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Medivolve's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Medivolve helps investors to forecast how Medivolve pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medivolve more accurately as focusing exclusively on Medivolve's fundamentals will not take into account other important factors: Medivolve Total Value Analysis
Medivolve is now anticipated to have takeover price of (972.47 K) with market capitalization of 2.51 M, debt of 965.43 K, and cash on hands of 5.8 M. The negative valuation of Medivolve may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should thoroughly investigate all of the Medivolve fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(972.47 K) | 2.51 M | 965.43 K | 5.8 M |
Medivolve Investor Information
About 12.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.76. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medivolve had not issued any dividends in recent years. The entity had 1:10 split on the 23rd of October 2015. Based on the measurements of operating efficiency obtained from Medivolve's historical financial statements, Medivolve is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Medivolve Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Medivolve has an asset utilization ratio of 146.43 percent. This implies that the Company is making $1.46 for each dollar of assets. An increasing asset utilization means that Medivolve is more efficient with each dollar of assets it utilizes for everyday operations.Medivolve Ownership Allocation
Medivolve maintains a total of 27.02 Million outstanding shares. Medivolve secures 12.01 % of its outstanding shares held by insiders and 0.0 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Medivolve Profitability Analysis
The company reported the revenue of 86.82 M. Net Loss for the year was (6.61 M) with profit before overhead, payroll, taxes, and interest of 36.57 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Medivolve's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Medivolve and how it compares across the competition.
About Medivolve Valuation
The pink sheet valuation mechanism determines Medivolve's current worth on a weekly basis. Our valuation model uses a comparative analysis of Medivolve. We calculate exposure to Medivolve's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medivolve's related companies.It is a social-impact investment focused company Investing resources, funds and bandwidth for the betterment of the human condition through medical sciences, climate change and technology. Copper One Inc. was incorporated in 2005 and is headquartered in Toronto, Canada. Medivolve operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 210 people.
8 Steps to conduct Medivolve's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Medivolve's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Medivolve's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Medivolve's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Medivolve's revenue streams: Identify Medivolve's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Medivolve's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Medivolve's growth potential: Evaluate Medivolve's management, business model, and growth potential.
- Determine Medivolve's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Medivolve's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Medivolve Growth Indicators
Investing in growth stocks can be very risky. If the company such as Medivolve does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 405.2 M | |
| Retained Earnings | -61.2 M |
Complementary Tools for Medivolve Pink Sheet analysis
When running Medivolve's price analysis, check to measure Medivolve's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medivolve is operating at the current time. Most of Medivolve's value examination focuses on studying past and present price action to predict the probability of Medivolve's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medivolve's price. Additionally, you may evaluate how the addition of Medivolve to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |